Overjet Periapical Radiolucency Assist
Overview
Overjet Periapical Radiolucency Assist is a cutting-edge AI tool designed to revolutionize dental care by enhancing diagnostic accuracy and streamlining treatment planning. The platform leverages advanced artificial intelligence to analyze dental radiographs, specifically aiding dentists in detecting and segmenting instances of periapical radiolucency (PARL) on periapical X-rays for patients aged 12 and above. It provides objective analysis alongside clinical expertise, helping dentists diagnose issues more quickly and accurately. Beyond PARL, Overjet’s broader AI platform also identifies cavities, periodontal diseases, and bone loss with precision. The software generates clear, easy-to-understand reports and visual overlays that help dentists explain diagnoses and treatment options to patients, significantly improving patient communication and case acceptance. Overjet aims to automate administrative work, enhance clinical decisions, and ensure every patient receives exceptional care.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered periapical radiolucency (PARL) detection and segmentation
- Automated detection of caries and bone loss on radiographs
- Enhanced diagnostic accuracy and consistency
- Patient education tools with visual overlays on X-rays
- Integration with major practice management and imaging systems
- Automated dental insurance verification and claims processing support
- Streamlined clinical workflows and reduced administrative burden
- Clinical decision support for treatment planning
- Provider performance dashboards and quality assurance tools
- Voice AI Suite for automated charting and visit summaries
Use Cases
- Enhancing diagnostic accuracy for dentists and hygienists
- Improving patient communication and increasing case acceptance
- Streamlining administrative tasks and optimizing practice operations
- Supporting dental insurance companies for claims review and adjudication
- Facilitating dental education and training for students and professionals
- Identifying treatment opportunities and boosting practice production
What Physicians Need to Know
Leverage Overjet's Periapical Radiolucency Assist as a decision-support tool, not a replacement for clinical judgment. Always correlate AI findings with clinical examination, patient symptoms, and history. Utilize the visual overlays during patient consultations to enhance understanding and foster trust, which can significantly improve case acceptance for recommended treatments. Integrate the AI insights into your existing workflow to streamline diagnostics and treatment planning, focusing on early detection of periapical pathologies to enable timely intervention. Remember that the AI is FDA-cleared for detection and segmentation of PARLs on periapical radiographs for patients aged 12 and older.
Overjet's platform, including PARL Assist, is designed for seamless integration with major digital imaging systems and popular practice management software (PMS) such as Carestack, Denticon, Dentrix, Eaglesoft, Open Dental, and Practice-Web. This allows for direct overlay of AI findings on radiographs within your existing workflow, minimizing disruption and training requirements. The system also supports integration with various imaging modalities, including bitewings, periapicals, panoramic, and with its CBCT Assist, 3D CBCT scans.
Details
| Category | Dental AI |
| Pricing |
Subscription-based
|
| Deployment | Cloud-based (SaaS) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated Overjet Periapical Radiolucency Assist received FDA 510(k) clearance (K231678) on September 21, 2023. This marks Overjet's 5th FDA clearance, making it the first and only dental AI provider capable of detecting and outlining instances of PARL on periapical radiographs for patients aged 12 and above. Overjet also holds FDA clearances for AI-powered bone level measurements and caries segmentation. |
| Integrations | |
| EHR | Not specified |
| Specialties | Dentistry |
What the Web Says
Overjet Periapical Radiolucency Assist is an FDA-cleared AI tool designed to help dental professionals detect and outline periapical radiolucencies (PARLs) on X-rays, which can indicate infection or inflammation at the tooth root. It aims to improve diagnostic accuracy, enhance patient education through visual aids, and streamline workflows. While some dentists find it a valuable second opinion and a good patient communication tool, others report issues with false positives and negatives, as well as concerns about customer service and data security.
Overall: MixedStrengths
- Enhanced diagnostic accuracy and early detection of pathologies, including PARLs.
- Improved patient education and trust through visual aids that highlight areas of concern on X-rays.
- Increased efficiency in dental practices by automating routine tasks and accelerating diagnostic workflow.
- FDA clearance for detecting and outlining PARLs, bone loss, and caries.
- Integration with existing dental practice management software.
- Potential for faster insurance claim processing and higher approval rates due to objective evidence.
Limitations
- Reports of false positives and false negatives, leading to potential misdiagnosis or undermining dentist's credibility.
- Can be glitchy and inconsistent in performance.
- Initial setup and training are required for integration into existing systems.
- Accuracy is highly dependent on the quality of the dental radiographs.
- Concerns about customer service and inconsistent billing.
- Some dentists prefer alternative AI solutions like Pearl, citing better UI or overall experience.
Based on reviews from: Reddit, Futurepedia, PMC, Overjet.ai, The Molar Report, Becker's Dental Review, Capterra, G2, AI Dental Tools
Last updated: 2026-07-20
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Overjet Periapical Radiolucency Assist
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Overjet Periapical Radiolucency Assist.
First-of-its-kind, FDA-cleared PARL segmentation capabilities
Overjet









